In vivo and in silico alpha-synuclein propagation dynamics: The role of genotype, epicentre, and connectivity

Neurodegeneration observed in synucleinopathies, like Parkinsons disease (PD), are hypothesized to be a consequence of the progressive accumulation and spread of misfolded alpha-synuclein (aSyn) throughout the brain. Here, we study the generalizability of this hypothesis across multiple biologically-relevant factors including genotype, aSyn species, and regional vulnerability (i.e.: does the introduction of aSyn into different brain regions have a similar impact) using a detailed longitudinal brain (using magnetic resonance imaging; [MRI]) and behavioural approaches. We first examined wild-type and M83 A53T hemizygous transgenic (engineered to over-express human aSyn) C57BL/6 x C3H mice receiving striatal inoculation with human or mouse preformed fibrils (PFFs) (n=89 mice at the last time point; n=687 MRI). Longitudinal analyses demonstrated a time-dependent increase in network-like atrophy and motor deficits, generalized across genotype and PFF species. We further derived latent dimensions relating brain-behaviour relationships revealing a pattern of sex- and genotype-relevant atrophy. Overall, atrophy was most prominent in M83 mice with mouse PFFs, while human PFFs or wild-type hosts showed attenuated effects. Changing the inoculation site to the hippocampus, a major connectivity hub, revealed differential regional vulnerability in the form of localized atrophy. Computational models previously validated in clinical PD further indicated regional vulnerability with increased predictive ability for atrophy patterns associated with striatal compared to hippocampal inoculation. Our findings reveal atrophy resulting from aSyn spreading is generalizable across genotype and PFF species, but not disease epicentres, emphasizing the role of regional vulnerability in disease progression.